2004
DOI: 10.1016/j.pain.2004.01.035
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of morphine analgesia by site-specific N -methyl-d-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time

Abstract: Pharmacological blockade of N-methyl-D-aspartate (NMDA) receptors can modulate morphine analgesia in experimental animals and humans. However, this literature is highly inconsistent, with NMDA receptor antagonists variously shown to potentiate, attenuate or produce no effect on morphine analgesic magnitude. A number of factors influencing this modulation have been proposed, but no one has examined such factors simultaneously, and all existing studies in mice were conducted exclusively in male subjects. Thus, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
48
2

Year Published

2004
2004
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 70 publications
(55 citation statements)
references
References 56 publications
5
48
2
Order By: Relevance
“…The decrease in morphine analgesia found in the KO mice used in this study is consistent with others reports using pharmacological blockade of the NMDA receptor for morphine analgesia. For instance, dextromethorphan (a low affinity and non competitive antagonist) attenuates morphine analgesia at high dose, and the polyamine NR2B antagonist Ro 25-6981 attenuates morphine analgesia at all doses examined [27]. However, the present results also differ from other studies that evaluated the effect of NR2B receptor antagonism in morphine analgesia [3,9].…”
contrasting
confidence: 97%
See 2 more Smart Citations
“…The decrease in morphine analgesia found in the KO mice used in this study is consistent with others reports using pharmacological blockade of the NMDA receptor for morphine analgesia. For instance, dextromethorphan (a low affinity and non competitive antagonist) attenuates morphine analgesia at high dose, and the polyamine NR2B antagonist Ro 25-6981 attenuates morphine analgesia at all doses examined [27]. However, the present results also differ from other studies that evaluated the effect of NR2B receptor antagonism in morphine analgesia [3,9].…”
contrasting
confidence: 97%
“…Functionally, NMDA receptors are involved in coordinating motor responses [4,5,28], and are suggested to play a critical role in mediating pain and analgesia [29], including the analgesic effects of morphine [13,19,20,27]. …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The distinction between the latter two types can be considered the difference between 'quantitative' and 'qualitative' sex differences. Although attention has mostly been paid to documenting quantitative sex differences in pain, a growing number of examples of qualitative differences in pain have been reported 31,39,43,[53][54][55][56][57][58][59][60][61][62][63][64] , and these promise to be far more important in the long run. As a practical matter, analgesics are routinely titrated according to their effect, which will effectively mitigate any sex differences along with other sources of inter-individual variability.…”
Section: Male Onlymentioning
confidence: 99%
“…Nature Reviews | Neuroscience qualitative sex differences in the midbrain, spinal cord and the primary afferent -are currently more comprehensively documented than the others. Multiple laboratories have observed that the midbrain-brain stem neural circuit subserving stress-induced analgesia, κ-opioid (and possibly μ-opioid) analgesia, morphine tolerance and morphine hyperalgesia in mice contains NMDAtype glutamate receptors (NMDARs) in males 49,56,57,[88][89][90] but not females; in many cases, females seem to use melanocortin 1 receptors (MC1Rs) instead 39,54,91 . In these studies, pharmacological antagonism with non-competitive NMDAR antagonists (for example, MK-801) blocks the phenomena in male but not female mice at any dose.…”
Section: Nature Reviews | Neurosciencementioning
confidence: 99%